Functional results from GSEA demonstrate that POLD4 has the potential to influence cancer development and progression via various mechanisms, including the regulation of immune responses such as modulating myeloid cell-mediated immunity, T-cell proliferation, leukocyte-mediated immune regulation, and involvement in immune response cell activation. This evidence concerns the gene POLD4 and cancer.